Patents Assigned to Ischemix, Inc.
  • Publication number: 20120058957
    Abstract: Peptide compounds and methods for upregulating expression of a gene encoding an antioxidative enzyme, such as superoxide dismutase or catalase, to counteract harmful oxidative effects of reactive oxygen species and other free radicals are described. The peptide compounds may be used to treat or prevent diseases and conditions characterized by undesirable elevation of reactive oxygen species and other free radicals, to upregulate AP-1 gene expression, and to treat pain. The peptide compounds may be used as components of pharmaceuticals and dietary supplements.
    Type: Application
    Filed: August 26, 2011
    Publication date: March 8, 2012
    Applicant: Ischemix, Inc.
    Inventor: Victor E. Shashoua
  • Patent number: 8034774
    Abstract: Peptide compounds and methods for upregulating expression of a gene encoding an antioxidative enzyme, such as superoxide dismutase or catalase, to counteract harmful oxidative effects of reactive oxygen species and other free radicals are described. The peptide compounds may be used to treat or prevent diseases and conditions characterized by undesirable elevation of reactive oxygen species and other free radicals, to upregulate AP-1 gene expression, and to treat pain. The peptide compounds may be used as components of pharmaceuticals and dietary supplements.
    Type: Grant
    Filed: November 21, 2007
    Date of Patent: October 11, 2011
    Assignee: Ischemix, Inc.
    Inventor: Victor E. Shashoua
  • Patent number: 7524819
    Abstract: Peptide compounds and methods for upregulating expression of a gene encoding an antioxidative enzyme, such as superoxide dismutase or catalase, to counteract harmful oxidative effects of reactive oxygen species and other free radicals are described. The peptide compounds may be used to treat or prevent diseases and conditions characterized by undesirable elevation of reactive oxygen species and other free radicals, to upregulate AP-1 gene expression, and to treat pain. The peptide compounds may be used as components of pharmaceuticals and dietary supplements.
    Type: Grant
    Filed: November 24, 2004
    Date of Patent: April 28, 2009
    Assignee: Ischemix, Inc.
    Inventor: Victor E. Shashoua
  • Publication number: 20090082281
    Abstract: Peptide compounds and methods for upregulating expression of a gene encoding an antioxidative enzyme, such as superoxide dismutase or catalase, to counteract harmful oxidative effects of reactive oxygen species and other free radicals are described. The peptide compounds may be used to treat or prevent diseases and conditions characterized by undesirable elevation of reactive oxygen species and other free radicals, to upregulate AP-1 gene expression, and to treat pain. The peptide compounds may be used as components of pharmaceuticals and dietary supplements.
    Type: Application
    Filed: November 21, 2007
    Publication date: March 26, 2009
    Applicant: Ischemix, Inc.
    Inventor: Victor E. Shashoua